Show simple item record

dc.contributor.authorRubio, María.
dc.contributor.authorTravaglianti, Mónica.
dc.date.accessioned2020-12-01T21:07:45Z
dc.date.available2020-12-01T21:07:45Z
dc.date.issued2020-04-01
dc.identifier.citationRev Enferm Neonatal. 2020;32:27-39.en_US
dc.identifier.issn2591-6424
dc.identifier.urihttps://riu.austral.edu.ar/handle/123456789/1010
dc.description.abstractHospitalized children are exposed to multiple pain- ful procedures. Each care center should implement a comprehensive program for the prevention and ma- nagement of pain in the newborn that includes us- ing strategies for routine evaluation, minimizing the number of painful procedures, reducing exposure to environmental stimuli such as light and noise, and us- ing protocols that incorporate the use of non-pharma- cological and pharmacological measures effectively. With regard to the administration of drugs, it is essen- tial to carefully select those who present greater evi- dence of efficacy and safety. Neonates constitute the population with the least in- formation regarding the dose, pharmacokinetic and pharmacodynamic behavior of medications because there are few robust clinical studies in patients of this age range. However, knowing the characteristics of the medi- cations currently available for the management of sedo-analgesia in the neonatal population is a funda- mental objective for the proper, safe and efficient use of these drugs. This article develops the most frequently used in this population.en_US
dc.description.sponsorshipAcceso Free: https://drive.google.com/file/d/1rwPaCVxRN-e54DzAaaamdmF-CVRqXSpg/viewen_US
dc.language.isoesen_US
dc.publisherFUNDASAMIN (Fundación para la Salud Materno Infantil)en_US
dc.subjectPainen_US
dc.subjectNeonateen_US
dc.subjectPharmacological treatmenten_US
dc.subjectAnalgesicsen_US
dc.titleTratamiento farmacológico del dolor del recién nacidoen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record